1. Introductory Text

  2. Article 1.Great Britain is free of Aujeszky's disease and vaccination is...

  3. Article 2.Pigs intended for slaughter dispatched to Great Britain must come...

  4. Article 3.Pigs intended for breeding destined for the Member States or...

  5. Article 4.Pigs intended for production destined for the Member States or...

  6. Article 5.The serological tests carried out to monitor or detect Aujeszky’s...

  7. Article 6.Without prejudice to Article 10(3) of Directive 64/432/EEC, information on...

  8. Article 7.In the case of pigs destined for Great Britain from...

  9. Article 8.When pigs are transported to Great Britain, it is a...

  10. Article 9.Decision 2001/618/EC is repealed. References to the repealed Decision shall...

  11. Article 10.This Decision is addressed to the Member States.

    1. ANNEX I

      Member States or regions thereof free of Aujeszky’s disease and where vaccination is prohibited

    2. ANNEX II

      Member States or regions thereof where approved national control programmes for the eradication of Aujeszky's disease are in place

    3. ANNEX III

      Standards for Aujeszky’s disease serological tests — Protocol for the enzyme linked immunosorbent assay (ELISA) for detecting antibodies to Aujeszky’s disease virus (whole virus), to glycoprotein B (ADV-gB), to glycoprotein D (ADV-gD) or to glycoprotein E (ADV-gE)

      1. 1. The institutes listed in paragraph 2(d) shall evaluate Elisa ADV-gE...

      2. 2. Standardisation, sensitivity and specificity of the test.

    4. ANNEX IV

      Criteria on the information to be provided on the occurrence of Aujeszky’s disease (AD) and on plans for the monitoring and eradication of this disease, to be provided in accordance with Article 8 of Council Directive 64/432/EEC

      1. 1. Member State:

      2. 2. Date:

      3. 3. Reporting period:

      4. 4. Number of holdings where AD has been detected by means...

      5. 5. Information on AD vaccination, serological investigations and categorisation of holdings...

      6. 6. Further information on serological monitoring in Artificial Insemination Centres, for...

    5. ANNEX V

    6. ANNEX VI